Cabot Corp (CBT) Stock AnalysisCBTCabot Corp

Cabot Corporation is a global specialty chemicals and performance materials company. The Company's principal products are reinforcing and specialty carbons, specialty compounds, conductive additives, carbon nanotubes, fumed metal oxides, inkjet colorants and aerogel. It operates through two segments: Reinforcement Materials and Performance Chemicals. Its reinforcing carbon products are used in tires and industrial products. In addition to its reinforcing carbons, it manufactures engineered elastomer composites (E2C) solutions that are composites of reinforcing carbons and rubber made using its patented elastomer composites manufacturing process. Under the Performance Chemicals segment, it designs, manufactures and sells materials that deliver performance in a range of customer applications across the automotive, construction, infrastructure, inkjet printing, electronics, and consumer products sectors and in applications related to the generation, transmission and storage of energy. It operates in the Basic Materials sector (MISCELLANEOUS CHEMICAL PRODUCTS industry).

Cabot Corp is currently not a strong buy due to its low RSI of 24.258, indicating oversold conditions, and a significant drop in Q3 earnings to only $6 million, down from $101 million last year. However, the stock has a forward P/E of 9.94, suggesting it may be undervalued, and analysts have a price target range from $70 to $100, with Truist maintaining a buy rating at $100. The main risk is the recent decline in earnings and net income, which fell to $0.12 per share from $1.86 per share year-over-year, indicating profitability challenges.

7 analysts cover CBT: 3 rate it Buy, 4 Hold and 0 Sell. The average price target is 66.33.